PrEP in Women: Unique Considerations and Strategies

Slides:

Advertisements

Similar presentations

PrEP: HIV Pre-exposure Prophylaxis Katherine Marx, MS, MPH, FNP-BC June 2014.

Advertisements

HIV treatment as prevention Stephen Kegg. 2 Learning Outcomes Overview of HIV management HIV transmission risks Current prevention strategies Which new.

Integration with ART for HIV+ Heterosexual men Risk of Resistance MSM High-risk women Young MSM of color Transgender women Long-term safety Provider attitudes.

HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.

Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.

Purpose Provide concepts and latest research findings related to prevention of mother-to-child transmission of HIV (PMTCT) for application in the workplace.

NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.

PMTCT Presented by: Ms T. Nondanyana (PMTCT COORDINATOR) Room: 129 Tel:

Richard Wolitski, PhD Division of HIV/AIDS Prevention Housing and Health : A CDC Perspective July 21, 2012 AIDS 2012 International Housing Summit World.

Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana: a simple mathematical modeling approach Dawn K.

East meets West: A Comparative Look at Governmental Response to HIV/AIDS in China and the U.S. Matt Klaber, FTS : The Game of Go. Fall Semester.

Viral load distribution 2012 among persons living with HIV and persons newly diagnosed Georgia, 2011.

Ten Most Wanted: 28 th November 2011 Item Code: UK/MEDed/2011/0269a Date of Prep: November 2011.

Summary of HIV Infection in Alaska, 1982–2015 Prepared by the State of Alaska Department of Health and Social Services, Division of Public Health, HIV/STD.

Understanding the Rationale of the 2015 WHO Guidelines on PrEP IAS Satellite Session Heather Watts M.D. Office of the Global AIDS Coordinator July 18,

A protocol in development IMPAACT Prevention Scientific Committee

2017 Key Considerations for adolescents and children & Key populations

HIV-Associated Weight Loss and Wasting

PrEP: A Case-by-Case Approach

HIV and the ART of Prevention

A Review of the Critical Role of Imaging in Primary Liver Malignancy

VL patient support: General education at different levels

Claire Gamble Friday 30th June 2017

Healthcare Strategies for HIV-Positive Girls and Women: Can We Do Better?

Rapid Diagnostics and Stewardship: Combating the Rise of Antimicrobial Resistance.

Managing Women Living With HIV Infection

Beyond Supportive Care for Lower-Risk Myelodysplastic Syndrome

Pediatric Antiepileptic Treatment Strategies

Stopping the Epidemic HIV Prevention Today

Lactation Ammenorrhoea Method (LAM)

Is Your Patient Engaged in Care

HPV-Related Disease: Separating Fact From Fiction

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

Statins, HIV, and CVD.

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations.

Agenda. Agenda HIV in the United States HIV in the United States (cont)

Is it Time for a Paradigm Change in HIV Management?

Overview. 5 Things You Need to Know About Statin Selection in Patients With HIV Infection.

Management of CMV in HSCT Recipients

Initiating Pre-exposure Prophylaxis The PrEP Checklist

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Practical Strategies to Reduce HF Hospitalizations in African American Patients.

HIV Treatment: What Can You Do to Get and Keep Patients in Care?

Personalized Therapy in Relapsed or Refractory CLL

Statins, HIV, and CVD.

PrEP Ongoing Care.

CMV in the HSCT Recipient

Battling the Flu: Latest Advances in the Influenza Treatment Arsenal

No. 342-Hepatitis B and Pregnancy

Considerations in Managing Seizures in Women

A Guideline-Based Approach to HCV Care

Insulin in Diabetes Management: Effective Patient Selection Is Key

Reconciling Aging With HIV

Clinical Challenges and Updates in Managing Seizure Clusters

Peanut Allergy Immunotherapy

Transitioning Therapy in PAH: Practical Strategies and Considerations

Case Studies in Peanut Allergy Immunotherapy

Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.

Expert Perspectives.

U=U Guidance for Implementation in Clinical Settings

Shared Decision Making in MS

Characterizing Virological Suppression in Today's Treatment Paradigm

Undetectable = Untransmittable

Motor Fluctuations in PD

Best Practices in Building HIV Care Networks

A Fresh Perspective on Hypoactive Sexual Desire Disorder

Presentation transcript:

PrEP in Women: Unique Considerations and Strategies

What Is PrEP?

PrEP Is Not Just for MSM

Determining Who Is at Substantial Risk for HIV Infection

Risk Factors for Acquiring HIV Infection in Heterosexual Women

Case Cindy, a 36-Year-Old Woman

Undetectable Viral Load

Case (cont)

Case (cont)

Case (cont) Six Months After Starting PrEP, Cindy Wants to Have a Child

PrEP Is Even More Important During Pregnancy

PrEP During Breastfeeding?

Safety of PrEP During Pregnancy and Breastfeeding

PrEP is Effective: Adherence Is Critical

Daily Adherence Is More Important in Women

When Does PrEP Start Working in Women?

Concluding Remarks

Abbreviations